DNAVSGRAL• 6 Months (Normalized)
DNA vs GRAL (Ginkgo Bioworks Holdings Inc. vs GRAIL Inc.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
GRAL Performance $136.57
+163.95%
GRAIL Inc.
Normalized Baseline0.00%
Alpha Spread Margin GRAL LEADS
-163.95 pts
GRAL outperforming by 163.95 percentage points
DNAGRAL
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA GRAL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | DNA Price | DNA Gain (%) | GRAL Price | GRAL Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $136.57 | +163.95% | - | |
| Sep 28, 2026 | $10.46 | +52.26% | $132.63 | +156.34% | -104.08% |
| Sep 25, 2026 | $10.66 | +55.17% | $126.89 | +145.25% | -90.08% |
| Sep 24, 2026 | $10.25 | +49.20% | $125.21 | +142.00% | -92.80% |
| Sep 23, 2026 | $8.58 | +24.89% | $108.52 | +109.74% | -84.85% |
| Sep 22, 2026 | $9.37 | +36.39% | $108.52 | +109.74% | -73.35% |
| Sep 21, 2026 | $7.98 | +16.16% | $107.97 | +108.68% | -92.52% |
| Sep 18, 2026 | $7.88 | +14.70% | $80.77 | +56.11% | -41.41% |
| Sep 17, 2026 | $7.84 | +14.12% | $79.95 | +54.52% | -40.40% |
| Sep 16, 2026 | $7.06 | +2.77% | $75.11 | +45.17% | -42.40% |
| Sep 15, 2026 | $6.99 | +1.75% | $75.89 | +46.68% | -44.93% |
| Sep 14, 2026 | $7.01 | +2.04% | $75.53 | +45.98% | -43.94% |
| Sep 11, 2026 | $6.75 | -1.75% | $76.23 | +47.33% | -49.08% |
| Sep 10, 2026 | $6.78 | -1.31% | $77.56 | +49.90% | -51.21% |
| Sep 09, 2026 | $6.79 | -1.16% | $77.48 | +49.75% | -50.91% |
Page 1 of 9